<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01303484</url>
  </required_header>
  <id_info>
    <org_study_id>Clasado2011</org_study_id>
    <nct_id>NCT01303484</nct_id>
  </id_info>
  <brief_title>The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People</brief_title>
  <acronym>PRIMES</acronym>
  <official_title>A Randomised, Double-blind, Placebo Controlled Cross- Over Study to Determine the Effect of prebioticB-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clasado</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clasado</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of prebiotic B-GOS on the immune
      function, metabolism and gut microbiota of elderly people
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of B-GOS on immunity by measuring various inflammatory/immune biomarkers</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of B-GOS on the faecal microbiota composition of elderly persons</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of aging on body metabolites using NMR</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of B-GOS on gut permeability</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weekly assessment of stools and gastrointestinal symptoms</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Immunosenescence</condition>
  <arm_group>
    <arm_group_label>MDn</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B-GOS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prebiotic</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bi2munoÂ® GOS</intervention_name>
    <description>5.5g/day for 10 weeks</description>
    <arm_group_label>B-GOS</arm_group_label>
    <other_name>galactooligosaccharide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Maltodextrin</intervention_name>
    <description>5.5g daily for 10 weeks</description>
    <arm_group_label>MDn</arm_group_label>
    <other_name>Dextrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 65 and 80 years of age.

          -  In good general health

          -  The volunteer has given written informed consent to participate and is willing to
             participate in the entire study.

        Exclusion Criteria:

          -  History or evidence of disease of the gastrointestinal tract; such as tumour,
             irritable bowel syndrome, etc., within the previous 5 years.

          -  Family history of colorectal cancer in under 50's

          -  Consumed probiotic or prebiotic preparations on a regular basis (at least 3 times per
             week) in the last 2 weeks.

          -  Former participation in another study involving prebiotic or probiotic preparations or
             investigational drugs within the previous 6 months, or intention to use such drugs
             during the course of the study (please note sensory evaluations are still permitted).

          -  Undergone surgical resection of any part of the bowel.

          -  History of malignancy within the previous 5 years (with exception of well-treated
             basal cell carcinoma or in situ cervical carcinoma).

          -  Smoker

          -  Lactose intolerant

          -  Allergic to gluten

          -  Currently prescribed immunosuppressive drugs. Participants will be required to
             withdraw should they begin taking any of the ineligible medication.

          -  Intention to use regularly other medication which affects gastrointestinal motility
             and/or perception.

          -  History of alcohol or drug misuse.

          -  Suffer from any major conditions involving the following:

        Head, Ears, Eyes, Nose and Throat Dermatological/Connective tissue Coeliac disease
        Neurological Lymphatic Urogenital/Rectal Gastroenterological Abdominal Respiratory
        Cardiovascular Incontinence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn Gibson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading, United Kingdom</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Reading</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <last_update_submitted>March 24, 2016</last_update_submitted>
  <last_update_submitted_qc>March 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

